Trials / Completed
CompletedNCT00000443
Ondansetron Treatment for Alcoholism
Pharmacological Treatment for Alcoholism
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · NIH
- Sex
- All
- Age
- 25 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to: a) evaluate the effectiveness of ondansetron (Zofran) in the treatment of alcohol dependent patients; b) investigate whether early versus late onset alcoholism predicts treatment outcome; and c) determine whether the early and late onset groups respond differently to treatment. Individuals will be "typed" into early onset and late onset alcoholism groups. Individuals will be randomly assigned to a 12-week outpatient treatment program.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ondansetron (Zofran) |
Timeline
- Completion
- 2000-04-01
- First posted
- 1999-11-03
- Last updated
- 2005-06-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000443. Inclusion in this directory is not an endorsement.